MeningococcalPolysaccharideVaccine

MeningococcalPolysaccharideVaccine Struktur
CAS-Nr.
Englisch Name:
MeningococcalPolysaccharideVaccine
Synonyma:
MeningococcalPolysaccharideVaccine
CBNumber:
CB21402296
Summenformel:
Molgewicht:
0
MOL-Datei:
Mol file

MeningococcalPolysaccharideVaccine Eigenschaften

Sicherheit

MeningococcalPolysaccharideVaccine Chemische Eigenschaften,Einsatz,Produktion Methoden

Allgemeine Beschreibung

Meningococcal vaccine is an inactivated vaccine composedof capsular polysaccharide fragments of Neisseria meningitidis.There are four polysaccharide serotypes represented inthe vaccine: A, C, Y, and W-135. The type A polysaccharideconsists of a polymer of N-acetyl-O-mannosamine phosphate;the group C polysaccharide is mostly N-acetyl-Oacetylneuraminicacid. The antigens are conjugated to diphtheriatoxoid carrier. Indications are the following:
? Induction of active immunity against selected strains ofN. meningitidis
? Military recruits during basic training
? College freshmen and those living in dormitories
? Travelers to countries with epidemic meningococcal disease? Household or institutional contacts of those with meningococcaldisease
? Immunosuppressed persons (HIV, Streptococcus pneumoniae)
? To stop certain meningococcal group C outbreaks
? Persons aged 2 through 55 years of age at risk for invasivemeningococcal disease.

MeningococcalPolysaccharideVaccine Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


MeningococcalPolysaccharideVaccine Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 0)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate

  • MeningococcalPolysaccharideVaccine
Copyright 2019 © ChemicalBook. All rights reserved